ConductScience.org, home

Paper11222367

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.

Thomis DC and 6 others. Blood, 2001. Cited by 163 papers, by iCite.

Cite this record

ConductScience Library. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Papers, record 11222367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11222367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.
PubMed
Journal
Blood
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
163
iCite
Relative citation ratio, by iCite
2.77
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thomis DCD C
2Marktel SS
3Bonini CC
4Traversari CC
5Gilman MM
6Bordignon CC
7Clackson TT

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft vs Host DiseaseMajor topic
T-LymphocytesMajor topic
fas ReceptorMajor topic
Apoptosis
Bone Marrow Transplantation
Cross-Linking Reagents
Dose-Response Relationship, Drug
Gene Rearrangement
Humans
Immunomagnetic Separation
Lymphocyte Activation
Organic Chemicals
Recombinant Fusion Proteins
Retroviridae
Tacrolimus Binding Proteins
Time Factors
Transduction, Genetic
Transgenes

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
TGT06S01TelethonItalyPubMed

Source PubMed

Download CSV of grants

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.

PMIDTitleJournalYearIn PapersSource
40770153CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directions.Med Oncol2025https://conductscience.org/library/papers/40770153PubMed
39674824Evolving strategies for addressing CAR T-cell toxicities.Cancer Metastasis Rev2024https://conductscience.org/library/papers/39674824PubMed
38584391Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.Mol Ther2024https://conductscience.org/library/papers/38584391PubMed
37173999Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies.Cancers (Basel)2023https://conductscience.org/library/papers/37173999PubMed
37158883CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy.Cancer Cell Int2023https://conductscience.org/library/papers/37158883PubMed
36922828Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.J Transl Med2023https://conductscience.org/library/papers/36922828PubMed
36463361SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity.Sci Rep2022https://conductscience.org/library/papers/36463361PubMed
34948123
Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response.
Int J Mol Sci2021https://conductscience.org/library/papers/34948123PubMed
34841295Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.Cell Rep Med2021https://conductscience.org/library/papers/34841295PubMed
34638227Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors.Cancers (Basel)2021https://conductscience.org/library/papers/34638227PubMed
34412685Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.Stem Cell Res Ther2021https://conductscience.org/library/papers/34412685PubMed
33919245Pharmacologic Control of CAR T Cells.Int J Mol Sci2021https://conductscience.org/library/papers/33919245PubMed
33869011Strategies for Dodging the Obstacles in CAR T Cell Therapy.Front Oncol2021https://conductscience.org/library/papers/33869011PubMed
33329526Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.Front Immunol2020https://conductscience.org/library/papers/33329526PubMed
33013822TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals.Front Immunol2020https://conductscience.org/library/papers/33013822PubMed
32498368Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer.Cells2020https://conductscience.org/library/papers/32498368PubMed
31723811CAR T Cells: A Snapshot on the Growing Options to Design a CAR.Hemasphere2019https://conductscience.org/library/papers/31723811PubMed
30892136Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells.MAbs2019https://conductscience.org/library/papers/30892136PubMed
30796733Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors.Drugs2019https://conductscience.org/library/papers/30796733PubMed
29728788Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice.Med Oncol2018https://conductscience.org/library/papers/29728788PubMed

See all 66 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11222367

GET https://conductscience.org/api/papers/v1/11222367/cited_by?page=2